Autotransfusion Devices Market to exhibit a CAGR of 5.2% by 2032, owing to rising number of transplant procedures | insightSLICE
In 2021, the market for Autotransfusion Devices was estimated to be worth US$ 1.1 billion, and it is anticipated to expand at a CAGR of 5.2% through 2032.
In order to collect and re-infuse the patient’s blood into the body, autotransfusion devices are frequently employed. The strategies used by the human body to produce cells heavily rely on this kind of practice.
Access the sample report: https://www.insightslice.com/request-sample/904
The two basic types of autotransfusion are as follows: Before a procedure, blood can be autologously “pre-donated.” An intraoperative blood recovery device can also be used to collect it during and after the operation. The latter type of autotransfusion is used during operations where a significant amount of blood loss is anticipated.
This technology makes it possible to transfuse autologous blood, and most critically, it lowers the hazards associated with transfusing immunologically incompatible blood.
The key players of the Global Autotransfusion Devices Market are:
The leading companies involved in the autotransfusion devices market include Liva Nova, Zimmer Biomet Holdings, Medtronic Plc, Atrium Medical Corporation, Gen World Medical Devices, and ZKSK Technology among others.
Driving factors for the growth of Global Autotransfusion Devices Market
The market for autotransfusion devices is expanding primarily as a result of rising surgical operations and the incidence of chronic diseases. One of the main causes of the increase in the marketplace for autotransfusion devices is cardiovascular surgery.
The leading cause of mortality worldwide, based on the World Health Organization, is cardiovascular disease and heart attacks. Additionally, the need is growing as a result of the lack of blood donations.
Read more about the report inclusions: https://www.insightslice.com/autotransfusion-devices-market
Competition has a significant impact on market restrictions for autotransfusion devices. Allogenic blood donations and autotransfusion machines compete with one another.
Many hospitals can be hesitant to invest in the capital equipment required for autotransfusion because of financial constraints. The market may be constrained by this, particularly if the price of machinery and equipment is rising due to inflation.
Segments that show promising prospects:
The market leader in terms of revenue generation is the cardiovascular market due to the extensive usage of these devices throughout the heart and vascular operations.
This is partly because institutions have specialized divisions where blood transfusions are necessary, necessitating the need for numerous autotransfusion systems to meet the diverse transfusion needs of specialist diseases in distinct departments.
Off-Pump Autotransfusion Systems currently holds the largest market share within the specific product category and are anticipated to expand at a CAGR of 6.6% from 2019 to 2027.
The convenience of using the device and the fact that there is no blood loss throughout the transfusion process are the main forces behind off-pump transfusion. The effectiveness of off-pump transfusions and the fact that they have significantly lower postoperative mortality and morbidity, particularly in high-risk individuals, are major trends.
With the rise in cardiovascular procedures, the hospital sector will be the most important sector during the forecast period. Since cardiovascular organ transplantation is typically linked to blood loss and consequently necessitates a high degree of blood transfusion, it also holds a significant position in the end-user study of the market.
Regional performance of Autotransfusion Devices Market
The region of North America dominates the autotransfusion market as of 2020. Because of a variety of variables, including the existence of leading companies, the high amount of surgeries performed there, the accessibility of cutting-edge healthcare infrastructure, and advantageous social programs, which are also the main reason for North America’s market share.
North America is followed by Europe and the Asia-Pacific area. The need for autotransfusion devices in the European market is anticipated to increase due to the fast-rising number of surgeries, particularly in the UK, France, and Germany with such a heavy emphasis on intraoperative procedures.
Because of the introduction of new businesses over the projection period, the Asia-Pacific region is anticipated to have the greatest CAGR. Rapidly rising surgical rates are another factor fueling the expansion and expanding health systems support the availability of autotransfusion equipment.
Proceed to purchase: https://www.insightslice.com/buy-now/904
Report for Autotransfusion Devices covers detailed statistics and forecasts:
In the report titled “Global Autotransfusion Devices Market 2023-2032” projects for thew market are provided in forecast period of 2023 to 2032. Herein, the years 2021 served as the historical period for our report, simultaneously the year 2022 is serving as the stationary year prior to the forecast period of years 2023 to 2032.
The study on the autotransfusion devices market provides us with a precise analysis of the industry that paints a comprehensive picture of the market prospects of the industry, the leading companies in the sector, and the product distribution at the regional level.
The study also considers the competition environment, and the report will give an analysis of the major market participants in the global autotransfusion devices market as well as their market forecasts.
In addition, the report will include information on important advancements, global and regional sales networks, best practices, studies and development initiatives, the total number of employees, and executive management for all significant market participants.
Global Autotransfusion Devices Market Key Segments:
By Product type
- Autotransfusion systems
- Intraoperative
- Postoperative
- Dual Mode Autotransfusion
- Consumables
- Accessories
By Application type
- Cardiovascular Surgeries
- Orthopedic
- Neurological Surgeries Gynecological
- Obstetrics
By End-User
- Hospitals
- Specialty Clinics
- Others
By Geography
- North America
- United States
- Canada
- Rest of North America
- Europe
- Germany
- United Kingdom
- Italy
- France
- Spain
- Rest of Europe
- Asia Pacific
- Japan
- India
- China
- Australia
- Rest of Asia Pacific
- Middle East & Africa
- UAE
- Saudi Arabia
- South Africa
- Rest of Middle East & Africa
- South America
- Brazil
- Rest of South America
Related reports:
Global Cardiac Stimulant Market: https://www.insightslice.com/cardiac-stimulant-market
Global Artificial Blood Pump Market: https://www.insightslice.com/artificial-blood-pump-market
insightSLICE is a market intelligence and strategy consulting company. The company provides tailor-made and off the shelf market research studies. The prime focus of the company is on strategy consulting to provide end-to-end solutions. For more details, please contact our research and consulting team at info@insightslice.com.
Contact us:
Alex R
+1 707 736 6633
Editor Details
-
Company:
- insightSLICE
- Website:
